Home / Bortezomib / Canada
CA ATC L01XG01 · updated 2 Nov 2026
Bortezomib shortage in Canada
Is there a Bortezomib shortage in Canada?
Yes. As of 2 Nov 2026, 2 Bortezomib products are reported short in Canada, the first since 1 Dec 2023. No return date has been given. Main reason: manufacturing problem.
Also short in Italy, Spain, Sweden, New Zealand. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TARO-BORTEZOMIB (2.5mg Vial) | TARO PHARMACEUTICALS INC | 1 Dec 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT BORTEZOMIB (1) | TEVA CANADA LIMITED | 20 Jan 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.